Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

NCT05285553 is registered in ClinicalTrials.gov with CooperVision, Inc. as lead sponsor.

NCT NCT05285553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05285553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Lead sponsor
CooperVision, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 25, 2022
Completion date
June 30, 2030
Enrollment
900 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

myopia